SYNLOGIC, INC. (SYBX) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US87166L1008

Price
1.10 USD
Market cap
13.54 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

SYNLOGIC, INC. financials

Fiscal year2025
Revenue0.00 USD
Operating income-4.01 m USD
EBIT-1.01 m USD
Net income-1.01 m USD
Diluted EPS – continuing operations-0.08 USD

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About SYNLOGIC, INC.

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.